Cohen Buys Kestra Shares, Signals Board Confidence
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Raymond Cohen, Kestra Medical Technologies director, recently invested $200,000 in 10,000 shares, now holding 50,903 shares worth $1 million. This is his second open-market buy since joining the board in March 2025. Cohen, former CEO of Axonics, bought near lows, indicating potential upside in Kestras cardiac monitoring and patient care push. Despite a $144 million net loss and a $1.16 billion market cap, shares closed at $19.84 on April 2, down 17% over the past year. Cohens moves may signal board confidence, but investors should review fundamentals before investing.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/b62e123182a1a2a4